#195 on the rich list of 14,644 insiders
Suma M. Krishnan
President, R&D at Krystal Biotech. Based in Pittsburgh, Pennsylvania.
$1.41B
in disclosed stock, +$2.1M (+0.15%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 195th of 14,644
- Companies held
- 1
- Largest holding
- KRYS, 100.0% of total
- Latest SEC filing
- Sep 4, 2026
What the $1.41B is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Krystal Biotech KRYS Common Stock | Indirectly (see filing footnote) | 1,500,253 | $315.82 | $474M | 33.5% | Form 4, Feb 27, 2026 |
| Krystal Biotech KRYS Common Stock | Through Spouse | 1,482,825 | $315.82 | $468M | 33.1% | Form 4, Feb 27, 2026 |
| Krystal Biotech KRYS Common Stock | Directly | 1,302,145 | $315.82 | $411M | 29.1% | Form 4, Sep 4, 2026 |
| Krystal Biotech KRYS Common Stock | Through Krishnan Spousal Trust | 90,000 | $315.82 | $28.4M | 2.0% | Form 4, Sep 4, 2026 |
| Krystal Biotech KRYS Common Stock | Through Suma Mani Krishnan Trust | 51,010 | $315.82 | $16.1M | 1.1% | Form 4, Sep 4, 2026 |
| Krystal Biotech KRYS Common Stock | Through Krishnan Family Trust | 50,000 | $315.82 | $15.8M | 1.1% | Form 4, Sep 4, 2026 |
Share counts are the amounts Suma M. Krishnan reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Sold | KRYS | 1,992 | $362.65 | $722K | View |
| Sep 4, 2026 | Sold | KRYS | 1,242 | $361.61 | $449K | View |
| Sep 4, 2026 | Sold | KRYS | 2,320 | $360.47 | $836K | View |
| Sep 4, 2026 | Sold | KRYS | 3,392 | $359.39 | $1.2M | View |
| Sep 4, 2026 | Sold | KRYS | 3,180 | $358.42 | $1.1M | View |
| Sep 4, 2026 | Sold | KRYS | 3,962 | $357.57 | $1.4M | View |
| Sep 4, 2026 | Sold | KRYS | 565 | $363.34 | $205K | View |
| Sep 4, 2026 | Sold | KRYS | 2,006 | $355.57 | $713K | View |
| Sep 4, 2026 | Sold | KRYS | 520 | $354.54 | $184K | View |
| Sep 4, 2026 | Sold | KRYS | 1,329 | $364.48 | $484K | View |
| Sep 4, 2026 | Sold | KRYS | 826 | $365.41 | $302K | View |
| Sep 4, 2026 | Sold | KRYS | 399 | $366.56 | $146K | View |
| Sep 4, 2026 | Sold | KRYS | 3,267 | $356.37 | $1.2M | View |
| Jun 4, 2026 | Sold | KRYS | 320 | $300.75 | $96K | View |
| Jun 4, 2026 | Sold | KRYS | 593 | $302.25 | $179K | View |
| Jun 4, 2026 | Sold | KRYS | 247 | $303.17 | $75K | View |
| Jun 4, 2026 | Sold | KRYS | 400 | $304.89 | $122K | View |
| Jun 4, 2026 | Sold | KRYS | 480 | $305.87 | $147K | View |
| Jun 4, 2026 | Sold | KRYS | 240 | $311.65 | $75K | View |
| Jun 4, 2026 | Sold | KRYS | 12,729 | $307.81 | $3.9M | View |
| Jun 4, 2026 | Sold | KRYS | 3,803 | $308.89 | $1.2M | View |
| Jun 4, 2026 | Sold | KRYS | 2,801 | $309.95 | $868K | View |
| Jun 4, 2026 | Sold | KRYS | 2,039 | $310.94 | $634K | View |
| Jun 4, 2026 | Sold | KRYS | 1,348 | $307.09 | $414K | View |
| Mar 4, 2026 | Sold | KRYS | 407 | $257.32 | $105K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 192 | Robert D. Haas 10% owner, Levi Strauss &. San Francisco, CA | $1.44B |
| 193 | Kathleen M. Dolan Insider, MSG Knickerbockers. Yorktown Heights, NY | $1.44B |
| 194 | Steven I. Sarowitz Director, Paylocity Holding. Schaumburg, IL | $1.43B |
| 195 | Suma M. Krishnan President, R&D, Krystal Biotech. Pittsburgh, PA | $1.41B |
| 196 | David C. Paul Executive Chairman, Globus Medical. Audubon, PA | $1.41B |
| 197 | Valerijs Vavilovs 10% owner, Cipher Digital | $1.41B |
| 198 | Vasily Shikin Chief Technology Officer, AppLovin. Palo Alto, CA | $1.40B |
Other Krystal Biotech insiders
All KRYS insiders- Krish S. Krishnan$945MPresident and CEO. #286 overall
- Daniel Janney$26.9MDirector. #4126 overall
- Dino A. Rossi$14.7MDirector. #6556 overall
- Kathryn Romano$7.1MChief Accounting Officer. #11321 overall
- Andrew C. Orth$32KChief Commercial Officer. #5296 overall
Questions
How much stock does Suma M. Krishnan own?
Suma M. Krishnan holds $1,413,683,906 in listed stock based on SEC filings and current prices, mostly Krystal Biotech (KRYS). That ranks 195th on the Stock Rich List.
Is this Suma M. Krishnan's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Suma M. Krishnan last buy or sell stock?
The most recent open-market trade on file is a sale of 1,992 KRYS shares on Sep 4, 2026 at $362.65.